Company name: Cannabco Pharmaceutical
Description: Owner and operator of a pharmaceutical company intended to produce medical marijuana. The company’s production facilities is focused on producing medical cannabis and dried cannabis, enabling their customers to cultivate cannabis for medical purposes.
Year founded: 2014
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Start up capital raised (USD Million): 24.00
Business status: Startup
Ownership: Privately Held (no backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company reached a definitive agreement to acquire Jiminex through a reverse merger, resulting in the combined entity trading on the TSX Stock Exchange on June 26, 2018. Subsequently, the deal was cancelled on September 13, 2018.
Number of active investors:
Profile last updated: 13-Sep-2018
Last known valuation:
Last known valuation date: